|
Name |
4''-Dehydro-3-hydroxyterphenyllin
|
| Molecular Formula | C20H18O5 | |
| IUPAC Name* |
4-(2-hydroxy-3,6-dimethoxy-4-phenylphenyl)benzene-1,2-diol
|
|
| SMILES |
COC1=C(C(=C(C(=C1)C2=CC=CC=C2)OC)O)C3=CC(=C(C=C3)O)O
|
|
| InChI |
InChI=1S/C20H18O5/c1-24-17-11-14(12-6-4-3-5-7-12)20(25-2)19(23)18(17)13-8-9-15(21)16(22)10-13/h3-11,21-23H,1-2H3
|
|
| InChIKey |
QVPSTGJFYRHFSU-UHFFFAOYSA-N
|
|
| Synonyms |
CHEBI:67529; 4''-dehydro-3-hydroxyterphenyllin; CHEMBL1795347; 4''-deoxy-3-hydroxyterphenyllin; DTXSID101224121; Q27135998; 3',6'-Dimethoxy-1,1':4',1''-terbenzene-3,4,2'-triol; 3',6'-Dimethoxy-1,1':4',1''-terphenyl-2',3,4-triol; 3',6'-Dimethoxy[1,1':4',1''-terphenyl]-2',3,4-triol; 1296205-84-9
|
|
| CAS | 1296205-84-9 | |
| PubChem CID | 53262867 | |
| ChEMBL ID | CHEMBL1795347 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 338.4 | ALogp: | 4.1 |
| HBD: | 3 | HBA: | 5 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 79.2 | Aromatic Rings: | 3 |
| Heavy Atoms: | 25 | QED Weighted: | 0.599 |
| Caco-2 Permeability: | -5.024 | MDCK Permeability: | 0.00001610 |
| Pgp-inhibitor: | 0.03 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.141 |
| 30% Bioavailability (F30%): | 0.091 |
| Blood-Brain-Barrier Penetration (BBB): | 0.024 | Plasma Protein Binding (PPB): | 99.40% |
| Volume Distribution (VD): | 0.564 | Fu: | 1.31% |
| CYP1A2-inhibitor: | 0.926 | CYP1A2-substrate: | 0.867 |
| CYP2C19-inhibitor: | 0.807 | CYP2C19-substrate: | 0.065 |
| CYP2C9-inhibitor: | 0.724 | CYP2C9-substrate: | 0.83 |
| CYP2D6-inhibitor: | 0.539 | CYP2D6-substrate: | 0.888 |
| CYP3A4-inhibitor: | 0.325 | CYP3A4-substrate: | 0.34 |
| Clearance (CL): | 7.771 | Half-life (T1/2): | 0.814 |
| hERG Blockers: | 0.138 | Human Hepatotoxicity (H-HT): | 0.026 |
| Drug-inuced Liver Injury (DILI): | 0.871 | AMES Toxicity: | 0.346 |
| Rat Oral Acute Toxicity: | 0.257 | Maximum Recommended Daily Dose: | 0.062 |
| Skin Sensitization: | 0.885 | Carcinogencity: | 0.099 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.875 |
| Respiratory Toxicity: | 0.345 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005039 | ![]() |
0.753 | D06GCK | ![]() |
0.376 | ||
| ENC002858 | ![]() |
0.747 | D0R2OA | ![]() |
0.354 | ||
| ENC002453 | ![]() |
0.736 | D04AIT | ![]() |
0.347 | ||
| ENC005040 | ![]() |
0.694 | D0K8KX | ![]() |
0.340 | ||
| ENC000826 | ![]() |
0.628 | D0A1PX | ![]() |
0.333 | ||
| ENC005036 | ![]() |
0.619 | D09VXM | ![]() |
0.330 | ||
| ENC002758 | ![]() |
0.615 | D07MGA | ![]() |
0.323 | ||
| ENC005037 | ![]() |
0.602 | D0L6DA | ![]() |
0.320 | ||
| ENC002853 | ![]() |
0.602 | D0Y7EM | ![]() |
0.318 | ||
| ENC002756 | ![]() |
0.598 | D04BNP | ![]() |
0.316 | ||